IL128031A0 - Pyranoindole and carbazole inhibitors of cox-2 - Google Patents
Pyranoindole and carbazole inhibitors of cox-2Info
- Publication number
- IL128031A0 IL128031A0 IL12803197A IL12803197A IL128031A0 IL 128031 A0 IL128031 A0 IL 128031A0 IL 12803197 A IL12803197 A IL 12803197A IL 12803197 A IL12803197 A IL 12803197A IL 128031 A0 IL128031 A0 IL 128031A0
- Authority
- IL
- Israel
- Prior art keywords
- pyranoindole
- cox
- carbazole
- inhibitors
- carbazole inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68784996A | 1996-07-26 | 1996-07-26 | |
PCT/US1997/012782 WO1998004527A1 (en) | 1996-07-26 | 1997-07-22 | Pyranoindole and carbazole inhibitors of cox-2 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL128031A0 true IL128031A0 (en) | 1999-11-30 |
Family
ID=24762121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12803197A IL128031A0 (en) | 1996-07-26 | 1997-07-22 | Pyranoindole and carbazole inhibitors of cox-2 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0923552A1 (xx) |
JP (1) | JP2000515887A (xx) |
KR (1) | KR20000029545A (xx) |
CN (1) | CN1230948A (xx) |
AR (1) | AR008006A1 (xx) |
AU (1) | AU4043397A (xx) |
BR (1) | BR9710597A (xx) |
CA (1) | CA2261588A1 (xx) |
HU (1) | HUP9904054A2 (xx) |
IL (1) | IL128031A0 (xx) |
NZ (1) | NZ334320A (xx) |
WO (1) | WO1998004527A1 (xx) |
ZA (1) | ZA976611B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1104297B8 (en) * | 1998-07-09 | 2006-05-03 | Cephalon, Inc. | Compositions for the treatment of chronic lymphocytic leukemia |
PL1534305T3 (pl) | 2003-05-07 | 2007-03-30 | Osteologix As | Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie |
GB2422828A (en) * | 2005-02-03 | 2006-08-09 | Hunter Fleming Ltd | Tricyclic cytoprotective compounds comprising an indole residue |
GB0522908D0 (en) * | 2005-11-10 | 2005-12-21 | Merck Sharp & Dohme | Therapeutic agents |
US20140249193A1 (en) * | 2011-04-12 | 2014-09-04 | The Regents Of The University Of California | Modulators of mitochondrial protein import |
IL305573A (en) | 2021-03-15 | 2023-10-01 | Saul Yedgar | Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4686213A (en) * | 1986-08-15 | 1987-08-11 | American Home Products Corporation | Substituted 1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acids |
US4927842A (en) * | 1989-09-29 | 1990-05-22 | American Home Products Corporation | 2,3,4,9-tetrahydro-1H-carbazole acetic acid derivatives, composition and use as anti-inflammatories |
-
1997
- 1997-07-22 WO PCT/US1997/012782 patent/WO1998004527A1/en not_active Application Discontinuation
- 1997-07-22 KR KR1019997000603A patent/KR20000029545A/ko not_active Application Discontinuation
- 1997-07-22 EP EP97938009A patent/EP0923552A1/en not_active Withdrawn
- 1997-07-22 HU HU9904054A patent/HUP9904054A2/hu unknown
- 1997-07-22 IL IL12803197A patent/IL128031A0/xx unknown
- 1997-07-22 BR BR9710597A patent/BR9710597A/pt not_active Application Discontinuation
- 1997-07-22 JP JP10508916A patent/JP2000515887A/ja active Pending
- 1997-07-22 CN CN97197994A patent/CN1230948A/zh active Pending
- 1997-07-22 AU AU40433/97A patent/AU4043397A/en not_active Abandoned
- 1997-07-22 CA CA002261588A patent/CA2261588A1/en not_active Abandoned
- 1997-07-22 NZ NZ334320A patent/NZ334320A/en unknown
- 1997-07-24 ZA ZA976611A patent/ZA976611B/xx unknown
- 1997-07-25 AR ARP970103390A patent/AR008006A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2261588A1 (en) | 1998-02-05 |
BR9710597A (pt) | 1999-08-17 |
ZA976611B (en) | 1999-01-25 |
AR008006A1 (es) | 1999-11-24 |
KR20000029545A (ko) | 2000-05-25 |
EP0923552A1 (en) | 1999-06-23 |
CN1230948A (zh) | 1999-10-06 |
JP2000515887A (ja) | 2000-11-28 |
HUP9904054A2 (hu) | 2000-04-28 |
WO1998004527A1 (en) | 1998-02-05 |
NZ334320A (en) | 1999-10-28 |
AU4043397A (en) | 1998-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9700602A3 (en) | New inhibitors of bone-resorption and vitronectine-receptor-antagonists | |
EP1009415A4 (en) | INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES | |
PL331856A1 (en) | Heterocyclic inhibitors of metaloprotease | |
IL128217A0 (en) | Phosphatase inhibitors and methods of use thereof | |
IL122186A (en) | Heterocycles as inhibitors of leucotype adhesion and as vla-4-antagonists | |
PL331254A1 (en) | Phosphonianic inhibitors of matrix metaloproteases | |
EP0794789A4 (en) | PRENYL TRANSFERASE INHIBITORS | |
HU9702036D0 (en) | New heterocyclic compounds as inhibitors of leucocita-adhesion and wla-4-antagonists | |
NO975759D0 (no) | Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel | |
PL331346A1 (en) | Hppd gene and inhibitors | |
PL327569A1 (en) | Promedications of thrombosin inhibitors | |
PL318128A1 (en) | Polymer-polyol and method of obtaining polymer-polyols | |
PL334846A1 (en) | Sulphamidic inhibitors of metaloproteases | |
PL331047A1 (en) | Novel amidinic derivatives and their application as inhibitors of thrombosin | |
PL333434A1 (en) | Aminoguanidines and alkoxyguanidines as inhibitors of proteases | |
PL341335A1 (en) | Combination of ace and mmp inhibitors | |
PL331920A1 (en) | Spirocyclic inhibitors of metaloproteases | |
HUP0002427A3 (en) | Leptin as an inhibitor of tumor cell proliferation and use of leptin | |
PL329855A1 (en) | Inhibitors of s-cd23 formation and tumour necrosis factor release | |
AU6655098A (en) | Novel drilling device and method of use | |
EP0942957A4 (en) | ESSENTIAL OIL AND METHOD OF USE | |
HK1031128A1 (en) | Jnk3 modulators and methods of use | |
AU3118297A (en) | Sok-1 and methods of use | |
ZA976611B (en) | Pyranoindole and carbazole inhibitors of cox-2 | |
ZA9710989B (en) | Polyprolyl inhibitors of cyclophilin |